Natural Science   

In this pre-recorded presentation, Dr. Christopher J. Logothetis will talk about has longstanding interest and findings in genitourinary cancers-germ cell tumors, bladder, renal, and most recently in his career, prostate cancer. He will talk about his research experience that preceded the development of effective chemotherapy and extends to the current era of molecular targeted therapies and classification of cancer. He was among the first to test chemotherapy agents at a time of general skepticism that chemotherapy would be useful in advanced prostate cancer.

Dr. Logothetis has substantial experience both as an investigator in clinical and applied research and as a leader in multidisciplinary research programs. He served as Chairman of the Department of Genitourinary Medical Oncology at The University of Texas M. D. Anderson Cancer Center in Houston, Texas from 1993 to 2019. He holds the Roy M. and Phyllis Gough Huffington Distinguished Chair in Clinical Research in Urologic Oncology.